Abstract
Flow cytometry was applied to test for platelet-activating-factor receptor (PAF-R) presence on the membranes of acute myeloid leukemia (AML) cells. We have used six human AML cell lines and freshly taken density gradient separated blasts from the bone marrow of ten AML patients covering the majority of French–American–British (FAB) subtypes. Additionally, we have used one histiocytic lymphoma cell line and mature human granulocytes/monocytes as controls. Our results indicate lack of membrane PAF-R on AML of all FAB subtypes tested. This was particularly true for the more mature and differentiated subtypes M4 and M5, including monocytic cell elements, and the promyelocytic M3 AML. In contrast, membrane PAF-R could be easily detected in a histiocytic lymphoma cell line and mature granulocytes/monocytes from peripheral blood used as positive controls. In conclusion, this observation precludes the use of membrane PAF-R as an immunophenotypic marker for AML classification or detection of minimal residual disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Feller N, van der Pol MA, van Stijn A, Weijers GWD, Westra AH, Evertse BW, Ossenkoppele GJ, Schuurhuis GJ (2004) MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia. Leukemia 18:1380–1390
Nigam S, Kunkel G, Prescott SM (eds) (1996) Platelet-activating factor and related lipid mediators 2. Adv Exp Med Biol 416:1–401
Müller E, Dupuis G, Turcotte S, Rola-Pleszczynski M (1991) Human PAF receptor gene expression: induction during HL-60 cell differentiation. Biochem Biophys Res Commun 181:1580–1586
Vallari DS, Austinhirst R, Snyder F (1990) Development of specific functionally active receptors for platelet-activating factor in HL-60 cells following granulocytic differentiation. J Biol Chem 265:4261–4265
Donnard M, Guglielmi L, Turlure P, Piguet C, Couraud MJ, Bordessoule D, Denizot Y (2002) Membrane and intracellular platelet-activating receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia. Stem Cells 20:394–401
Cellai C, Laurenzana A, Vannucchi AM, Della Malva N, Bianchi L, Paoletti F (2002) Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells. FASEB J 16:733–735
Acknowledgements
E. Kulimova was supported by a fellowship from the European Society for Medical Oncology (ESMO).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berdel, W.E., Kulimova, E., Kolkmeyer, A. et al. Receptor for platelet-activating factor (PAF) is not detectable by flow cytometry on the surface of myeloid leukemic cells. Ann Hematol 84, 771–773 (2005). https://doi.org/10.1007/s00277-005-1088-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-005-1088-3